TIDMANIC
Agronomics Limited
03 November 2022
3rd November 2022
Agronomics Limited
("Agronomics" or the "Company")
Agronomics Capital Markets Day Thursday 3 (rd) November
Agronomics (AIM:ANIC), the leading listed company focused on the
field of cellular agriculture, would like to remind everyone that
the capital markets webinar will be taking place today, between
2:00 pm - 4:30 pm GMT, to introduce investors, analysts and media
to cellular agriculture and a selection of leading companies in the
portfolio covering cell culture and precision fermentation
technologies.
Agronomics Overview
2:00 - Anthony Chow, Co-founder of Agronomics
2:15 - Question time
Precision Fermentation Highlights - Dairy, Eggs and Contract
Manufacturing for Scale-up
2:30 - Jan Pacas, Founder & CEO of All G Foods
2:45 - Mark Warner, Co-founder & CEO of Liberation Labs
3:00 - Maija Itkonen, Co-founder & CEO of Onego Bio
3:15 - Question time
Cultivated Meat and Materials Highlights -Bluefin Tuna, Pork and
Leather
3:30 - Lou Cooperhouse, Co-founder & CEO of BlueNalu
3:45 - Krijn de Nood, Co-founder & CEO of Meatable
4:00 - Ingvar Helgason, Co-founder & CEO of VitroLabs
4:15 - Question time
For registration and further details, please use the following
link:
https://events.masterinvestor.co.uk/events/agronomics-capital-markets-day/
About Agronomics
Agronomics is a leading listed alternative proteins company with
a focus on cellular agriculture and cultivated meat. The Company
has established a portfolio of 24 companies at the Pre-Seed to
Series C stage in this rapidly advancing sector. It seeks to secure
minority stakes in companies owning technologies with defensible
intellectual property that offer new ways of producing food and
materials with a focus on products historically derived from
animals. These technologies are driving a major disruption in
agriculture, offering solutions to improve sustainability, as well
as addressing food security, human health, animal welfare and
environmental damage. This disruption will decouple supply chains
from the environment and animals, as well as being fundamental to
feeding the world's expanding population. A full list of
Agronomics' portfolio companies is available at
https://agronomics.im/ .
About Onego Bio Ltd
Onego Bio Ltd is a game-changing biotech company producing
animal-free egg proteins with precision fermentation. When
implemented in full scale, this new production method provides
significant benefits to the environment, food security, as well as
animal welfare. The team believes the chosen technology is superior
because of its efficiency and productivity. Based on the
anticipatory LCA published in Nature Food , the technology shows
potential to significantly reduce most agriculture-associated
impacts, such as global warming and land use.
Egg is one of the world's most used animal proteins and
difficult to replace with alternative ingredients. Onego Bio will
make it possible to manufacture the same delicious foods entirely
animal-free. Company aims to launch its first product
Bioalbumen(TM) as a food ingredient for food industry and later
enter the consumer market with its own branded products for baking
and cooking. Bioalbumen provides the nutritional and functional
upsides of egg white, without the environmental, ethical and
safety-related concerns.
Founded in 2022 by Maija Itkonen (CEO), Christopher Landowski
(CTO) and Jussi Joensuu (COO), Onego Bio is a VTT spin-off that
salutes the remarkable work done by VTT Technical Research Centre
of Finland for the next level cell ag products and applications.
Onego Bio's mission is to rethink eggs and give people access to
sustainable, delicious and healthy animal-free food. Learn more at
www.onego.bio and follow our journey in LinkedIn , Twitter and
Instagram .
About All G Foods
All G Foods know that proteins created through animal
agriculture can't feed the next generations of humans. The team's
mission is to design a sustainable food future - one that is
limitlessly good. All G Foods believe the solution to the growing
protein demand is innovative, affordable, delicious, nutritious,
and sustainable alternative proteins, and are leading technological
innovations for the creation of next generation dairy and meat. All
G Foods are a trajectory to develop the world's first-to-market
identical dairy milk, entirely animal free through precision
fermentation and are doing plant-based meat differently to any
other brand with their Love BUDS(TM) products.
About Liberation Labs
Liberation Labs was formed to address the growing fermentation
capacity gap in cellular agriculture by providing the industry with
the infrastructure to commercialise novel protein manufacturing at
the scale and cost structure required by the market. Specifically,
Liberation Labs is developing a global network of fit-for-purpose
precision fermentation facilities located in the geographies that
will drive market access for novel protein companies to
commercially succeed, enabling them to achieve price parity with
animal proteins. Founded by industry leaders with decades of
experience in deployment of precision fermentation facilities and
commercial expertise in fermentation market dynamics, our vision is
to enable the technology that frees the world from the costs of
industrialised agriculture.
About Meatable
Meatable is an innovative, Dutch food company, aiming to
deliver, at scale, the new natural , cultivated meat that looks
like, tastes like, and has the nutritional profile of traditional
meat. Its proprietary opti-ox(TM) technology enables Meatable to
produce meat rapidly, sustainably, and without harming animals.
Founded in 2018 by Krijn de Nood (CEO), Daan Luining (CTO), and Dr.
Mark Kotter (principal inventor of opti-ox(TM)technology), Meatable
has brought together a team of experts with unique knowledge in
fields including molecular biology, chemistry, tissue engineering,
bioprocess development, food safety, and food science to create the
new natural meat.
Follow Meatable : LinkedIn , Twitter , Instagram , Facebook
.
About BlueNalu
BlueNalu's mission is to develop great-tasting, healthy, safe
and trusted cell-cultured seafood products that support the
sustainability and diversity of our ocean. The company has
developed a robust pipeline of seafood products from a wide array
of species and plans to launch its first commercial product,
premium bluefin tuna toro, following regulatory approval. BlueNalu
is a member of the United Nations Global Compact and aligned with
the UN Sustainable Development Goals, a blueprint to achieve a
better and more resilient future for our planet. BlueNalu began its
operations in 2018 and is based in San Diego, California. To learn
more about BlueNalu, please visit www.BlueNalu.com
About VitroLabs
VitroLabs, founded in 2016 and headquartered in Milpitas
California, is a biotech company developing a scalable tissue
engineering platform for the efficient and environmentally friendly
production of leather from only a few cells. Combining advanced
tissue engineering processes with proprietary advances to achieve
commercial scale, VitroLabs is on a mission to produce cell
cultivated leather that achieves the look, feel and performance of
traditional leather without compromise. The cultivated leather
process involves taking a one-time collection of cells from an
animal, which then grows in a nutrient-rich environment. Without
ever going back to the animal again, the cells grow, divide, and
form into tissue. The composition of the material achieves the
complexity of traditional hides, containing a variety of proteins
that make up a durable and luxurious material when finished, but
without the need to go to animals as an ongoing source of hides.
The process is more environmentally sustainable and favorable for
animal welfare than that which is used to produce traditional
leather. For more information, visit www.vitrolabsinc.com .
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products
directly from cells, as opposed to raising an animal for slaughter,
or growing crops. This encompasses cell culture to produce
cultivated meat and materials, and fermentation processes that
harness a combination of molecular biology, synthetic biology,
tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply
traditionally derived from conventional agriculture is going to
change dramatically. We have already witnessed the first wave of
this shift with the consumer adoption of plant-based alternative
proteins but today, we are on the cusp of an even bigger wave of
change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists claims that
if we maintain existing animal protein consumption patterns, then
we will not meet the Paris Agreement's goal of limiting warming to
1.5
AT Kearney, a global consultancy firm, projects that cultivated
meat's market share will reach 35% by 2040. This combined with the
Good Food Institute's estimate that a US $1.8 trillion investment
will be required in order to produce just 10% of the world's
protein using this technology, means that we are on the cusp of a
multi-decade flow of capital to build out manufacturing facilities.
Funding in the field of cellular agriculture is accelerating,
however still less than US$ 4 billion has been invested worldwide
since the industry's inception in 2016.
For further information please contact:
Agronomics Beaumont Canaccord Cenkos Peterhouse TB Cardew
Limited Cornish Genuity Limited Securities Capital
Limited Plc Limited
The Company Nomad Joint Broker Joint Broker Joint Broker Public Relations
================ =================== =============== =============== =====================
Richard Roland Cornish Andrew Potts Giles Balleny Lucy Williams Ed Orlebar
Reed James Biddle Harry Rees Michael Charles Alistair Walker
Denham Eke Alex Aylen Johnson Goodfellow
(Head of Equities)
================ =================== =============== =============== =====================
+44 (0) 20
7930 0777
+44 (0) 7738
+44 (0) +44 (0) +44 (0) +44 (0) 724 630
1624 639396 207 628 +44 (0) 207 207 397 207 469 agronomics@tbcardew.c
info@agronomics.im 3396 523 8000 8900 0936 om
================ =================== =============== =============== =====================
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUUABRUVUARAA
(END) Dow Jones Newswires
November 03, 2022 03:00 ET (07:00 GMT)
Agronomics (LSE:ANIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agronomics (LSE:ANIC)
Historical Stock Chart
From Apr 2023 to Apr 2024
